Aims The objective of this umbrella review and meta‐analysis was to evaluate the effect of
diabetes on risk of dementia, as well as the mitigating effect of antidiabetic treatments …

Type 2 diabetes mellitus (T2DM) is an important risk factor for dementia. The possibility to
mitigate this risk by controlling T2DM is compelling; however, different glucose-lowering …

Abstract Background and Aims Little is known about the association between non‐alcoholic
fatty liver disease (NAFLD) and dementia. Given that hepatic steatosis is linked to abnormal …

The lack of effective treatments for dementia has led to explore the potential of antidiabetic
agents as a possible approach. This cross-sectional and population-based study aimed to …

Background Metformin has been suggested to reduce dementia risk; however, most
epidemiologic studies have been limited by immortal time bias or confounding due to …

We are witnessing a considerable increase in the incidence of Parkinson's disease (PD),
which may be due to the general ageing of the population. While there is a plethora of …

Introduction An increasing number of older patients has type 2 diabetes treated with different
oral antidiabetic agents whose safety may raise concern considering some particularities of …

Aims The association between metformin use and neurodegenerative disease (ND) onset
remains controversial. In this systematic review and meta‐analysis, we aimed to determine …

We aimed to summarise current evidence on different antidiabetic drugs to delay cognitive
impairment, including mild cognitive impairment, dementia, Alzheimer's disease (AD) and …

Adult cancer survivors may have an increased risk of developing ischemic stroke, potentially
influenced by cancer treatment-related factors and shared risk factors with stroke. However …